---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-051382"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:59:08.900994+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences prices $75M underwritten offering of common stock and warrants

## Summary
- Offering: 10.8M shares + 1.4M pre-funded warrants at $6.14/$6.139995 per unit; gross proceeds ~$75M.
- Net proceeds ~$70M after discounts and expenses, expected close Nov 12, 2025.
- Each whole warrant exercises at $7.25/share, 5-year term; 4.99% beneficial ownership cap applies.
- Proceeds to fund R&D for ARCUS gene editing pipeline and working capital.
- Guggenheim Securities sole book-runner; participation from Aberdeen, Bleichroeder, Driehaus, and others.

## SEC filing metadata
- accession: 0001628280-25-051382
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/0001628280-25-051382-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/dtil-20251110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-051382
- JSON: https://secwatch.observer/filing/0001628280-25-051382.json
- Plain text: https://secwatch.observer/filing/0001628280-25-051382.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.